Webinar: Antibody Discovery – Select Better Lead Candidates in Under 1 Week
Learn how we enable lead candidate down-selection in 1 day by performing functional characterization during primary screening. Case studies highlight how our customers are dramatically accelerating development of next-generation antibody therapeutics.
Webinar: Accelerating Antibody Discovery in the Modern Therapeutic Landscape
Learn how antibody discovery is changing in today’s therapeutic space. Case studies presented by Abveris highlight accelerated development of next-generation antibody therapeutics.
Application Note: Rapid Selection of Antibodies Against Membrane Targets using Cell-Binding Assays and the Opto™ Plasma B Discovery
Find out how the Opto Plasma B Discovery workflow simplifies and dramatically reduces the time needed to down-select potential lead candidates, even for difficult membrane proteins.
Application Note: Rapidly Discover and Select Potent Ligand/ Receptor Blocking Antibody Lead Candidates with Opto™ Plasma B Discovery
Discover how you can maximize hit recovery and rapidly down-select blocking antibodies from plasma B cells in a single day.
Application Note: Accessing Greater Antibody Sequence Diversity
See how you can discover >5,000 antigen-specific hits from a single plasma B cell sample and recover >650 unique BCR sequences in under 1 week.
Poster: Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2
Find out how B Cell Antibody Discovery on the Beacon system can be used to rapidly screen human B cell to discover antibodies against difficult targets such as viruses.
Poster: Plasma B Cell Cloning
Berkeley Lights and ChemPartner provide a case study in accelerated discovery of unique Anti-PD-L1 antibodies from spleen versus bone marrow of immunized mice, via single plasma B cell cloning on the Beacon platform.
Webinar: Antibody Engineering & Therapeutics Digital Week 2019
Learn about accelerating target-to-lead antibody candidate selection with the Beacon platform in this Antibody Engineering & Therapeutics Digital Week 2019 webinar.
Antibody Discovery Webinar: Digital Week 2018
Watch a 1-hour webinar from the 2018 Antibody Engineering & Therapeutics Digital Week titled, “Emerging Technologies for Finding Rare Antibodies,” featuring scientists from Berkeley Lights and Teva Pharmaceuticals.
Poster: Rapid Antibody Discovery on the Beacon System
This poster developed by Berkeley Lights and Pfizer demonstrates rapid antibody discovery on the Beacon platform, showing how it can rapidly isolate and screen thousands of primary ASCs in a single day.